EUSA Pharma Announces FDA Approval of Phase 3 Clinical Trial for Siltuximab in Hospitalized Patients With COVID-19 Associated Acute Respiratory Distress Syndrome

HEMEL HEMPSTEAD, United Kingdom & BURLINGTON, Mass.--(BUSINESS WIRE)--Jul 2, 2020-- |!| Keokuk